The Cancer Research Institute funds research aimed at furthering the development of immunological approaches to the diagnosis, treatment, and prevention of cancer. The Institute's mission is to bring effective immune system-based therapies to cancer patients sooner.

To this end, CRI offers its Clinic and Laboratory Integration Program (CLIP) Grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The program supports basic, pre-clinical, and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic.

The development of new and effective cancer treatment requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. This area of translational research—where laboratory findings move into clinical testing, and where questions from clinical studies are brought back into the lab—is critical to bringing new and better immunotherapies to patients.

The Cancer Research Institute established CLIP to support investigators who are studying critical topics at the intersection of laboratory and clinical research. CLIP grants provide up to $200,000 over a two-year period.

The deadline for the receipt of the Letter of Intent is December 1. Candidates will be notified by the end of January whether or not they have been invited to submit a full grant proposal. The full application is due March 1.